Last edition
News about "Cancer Treatment"
Onco-Innovations Subsidiary Partners with GSK on Real-World Oncology Data Research
Inka Health and GSK will collaborate to develop real-world data methodologies aimed at improving the applicability of oncology clinical trial findings across diverse patient populations and healthcare settings.
Cancer Treatment | 07/05/2026 | By News Bureau
Merck Completes USD 5.8 Billion Acquisition of Terns Pharmaceuticals to Strengthen Oncology Pipeline
Merck acquires Terns Pharmaceuticals, advancing development of next-generation therapies for chronic myeloid leukaemia.
Cancer Treatment | 06/05/2026 | By News Bureau
IMUNON Reports Phase 2 Data Showing Improved Survival in Advanced Ovarian Cancer
IMUNON reports updated Phase 2 data showing improved Overall Survival (OS) with IMNN-001 in advanced ovarian cancer.
Cancer Treatment | 26/03/2026 | By News Bureau
Zydus Launches World's First Nivolumab Biosimilar 'Tishtha' in India
Zydus Lifesciences has launched Tishtha, the world’s first biosimilar of the immunotherapy drug nivolumab, in India, aimed at expanding access to advanced cancer care by offering the treatment at nearly one-fourth the cost of the reference product for patients with multiple cancer types.
Cancer Treatment | 23/01/2026 | By News Bureau | 456
FIU Researchers Advance Functional Precision Medicine for Hard to Treat Cancers
FIU researchers are advancing functional precision medicine for hard-to-treat cancers, with new funding accelerating drug sensitivity testing to identify personalized, effective therapies beyond conventional genetic approaches.
Cancer Treatment | 22/01/2026 | By News Bureau | 142
Immorta Bio Reports Tumour Reduction Across Multiple Cancer Models with SenoVax
Immorta Bio has reported promising pre-clinical results showing that its anti-aging vaccine, SenoVax, reduced tumours across multiple validated cancer models. Developed in collaboration with academic institutions, the platform aims to dismantle tumour defense mechanisms and offer a non-toxic, longevity-driven approach to cancer treatment.
Cancer Treatment | 05/12/2025 | By Dineshwori | 560
Innovent Biologics and Takeda Finalise Global Collaboration for Next-Generation IO and ADC Therapies
As part of the agreement, Takeda will pay Innovent an upfront payment of USD1.2 billion, including a USD100 million equity investment at HKD112.56 per share.
Cancer Treatment | 05/12/2025 | By Dineshwori | 125
Accession Therapeutics Doses First Patient in Phase 1 Trial of TROCEPT-01
Accession Therapeutics has dosed the first patient in its Phase 1 trial of TROCEPT-01 (ATTR-01), a first-in-class tumour-activated viral immunotherapy. Designed for systemic delivery, the therapy aims to selectively generate a checkpoint inhibitor within tumours, offering a targeted approach to cancer treatment.
Cancer Treatment | 18/11/2025 | By Dineshwori | 144
Bayer and Kumquat Biosciences have begun a Phase-I trial of their KRAS G12D inhibitor targeting KRAS-mutated tumors, further bolstering Bayer’s precision oncology pipeline across pancreatic, colorectal, and lung cancers.
Cancer Treatment | 11/10/2025 | By Dineshwori | 666
Nucleus RadioPharma Receives Series A Extension Funding from AstraZeneca
Nucleus RadioPharma has closed its Series A extension round with new investor AstraZeneca.
Cancer Treatment | 06/06/2024 | By Aishwarya | 749
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy